Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Aalborg Universitets forskningsportal Hjem
Dansk
English
Hjem
Profiler
Projekter
Publikationer
Aktiviteter
Enheder
Faciliteter
Presse/medier
Priser
Forskningsdatasæt
Impacts
Søg efter ekspertise, navn eller tilknytning
Ralf Agger offentligt CV
Ralf Agger Undervisningsportfolio
Vis Scopus-profil
Ralf Agger
Lektor
Institut for Medicin og Sundhedsteknologi
Det Sundhedsvidenskabelige Fakultet
Medical Microbiology and Immunology
https://orcid.org/0000-0002-1434-5726
Telefon
+4599407570
E-mail
agger
hst.aau
dk
Selma Lagerløfs Vej 249
,
1-212
9260
Gistrup
Danmark
1981 …
2024
Publikationer pr. år
Vis
Fingerprint
Netværk
Projekter
(2)
Publikationer
(104)
Presse/medier
(6)
Lignende profiler
(6)
Ph.d.-vejledning
(1)
Fingerprint
Dyk ned i forskningsemnerne, hvor Ralf Agger er aktive. Disse emneetiketter kommer fra dennes persons arbejder. Sammen danner de et unikt fingerprint.
Sorter
Vægt
Alfabetisk
Immunology and Microbiology
Dendritic Cell
100%
T Cell
53%
Immunotherapy
50%
Electroporation
33%
Antibody Response
25%
Interleukin 2
25%
Mononuclear Cell
22%
Pembrolizumab
22%
Cancer Immunotherapy
20%
Vaccine Efficacy
19%
Macrophage
17%
Antigen-Presenting Cell
16%
Tumor-Associated Macrophage
16%
Humoral Immunity
16%
Melanoma Cell
16%
Positron Emission Tomography
16%
Cell Homing
16%
Interferon Gamma
16%
Endoplasmic reticulum
16%
Cytomegalovirus
16%
Polyinosinic:polycytidylic Acid
16%
Quantitative Reverse Transcription Polymerase Chain Reaction
16%
Tumor Vascularization
16%
Inbred Rat Strain
16%
C57BL 6 Mouse
16%
CD25
16%
Interleukin 20
16%
Lymphokine Activated Killer Cell
16%
Immunity
16%
T-Helper Cell
13%
Immunocompetent Cell
13%
Mouse
13%
CD11c
11%
Monoclonal Antibody
11%
Natural Killer Cell
11%
Cytotoxic T-Cell
11%
CD36
8%
Adjuvant
8%
Central Vein
8%
Peritoneal Cavity
8%
Perivascular Space
8%
Syngenic
8%
Precursor
8%
C3H/He Mouse
8%
C57BL Mouse
8%
Tumor Cell
8%
Antigen Specificity
8%
Inguinal Lymph Node
8%
Spleen Lymph Node
8%
Interferon Alfa
8%
Keyphrases
Magnetic Resonance Imaging
16%
Positron Emission Tomography
16%
T Cell Homing
16%
Tumor
16%
124I
16%
Mouse Dendritic Cells
16%
Optimal Target
16%
Antigen Delivery
16%
Lymphokine-activated Killer Cells
16%
Strain Specificity
16%
Lymphokine-activated Killers
16%
LAK Cells
16%
Killer T Cells
16%
Tumor-bearing Animals
16%
Tumor Localization
16%
Tyrosinase
16%
Antitumoral Activity
16%
Tumor Blood Supply
16%
Cholesterol-binding Motifs
16%
Vaccination Protocols
16%
Bovine Serum Protein
16%
Cell Homing
16%
Cyclic GMP-AMP Synthase (cGAS)
16%
Small Animal
16%
Circulating Tumor DNA (ctDNA)
16%
Tumor Lysate
16%
Azoxymethane
16%
Solid Tissue
16%
Colon Tumor
16%
Local Immune Response
16%
Tumor-associated Macrophages
16%
Tumor Biopsy
16%
Mouse Spleen
16%
Intravenous Injection
16%
Leukocyte Integrins
16%
Injection Route
16%
Interdigitating Dendritic Cell
16%
Splenic Dendritic Cell
16%
Intracellular Antigens
16%
Resident Peritoneal Macrophages
16%
IL-20
16%
Peritoneal Mouse
16%
Ras GTPase-activating Proteins
16%
Interleukin-20
16%
Dendritic Cell Migration
16%
MART-1
13%
Tumor Tissue
12%
CD64
11%
High-dose interleukin-2
8%
CD8+ T Cells
8%
Medicine and Dentistry
Dendritic Cell
83%
T Cell
35%
Immunotherapy
25%
Mononuclear Cell
22%
Metastatic Melanoma
20%
In Vitro
19%
Neoplasm
19%
T-Helper Cell
19%
Immune Response
17%
Nodular Melanoma
16%
Gamma Interferon
16%
Cancer Immunotherapy
16%
Polyinosinic Polycytidylic Acid
16%
Irreversible Electroporation
16%
Pancreas Cancer
16%
Liver Metastasis
16%
Tyrosinase
16%
Quantitative Reverse Transcription Polymerase Chain Reaction
16%
Antibody Response
16%
Cytomegalovirus
16%
Antigen Presenting Cell
16%
Fusion Protein
10%
Immunocompetent Cell
9%
Biopsy
8%
Antigen Specificity
8%
Prognostic Factor
6%
Macrophage
6%
Adjuvant
6%
DNA RNA Hybridization
6%
Maturation
6%
T-Cell Response
5%
Specific Tumor
5%
Pembrolizumab
5%
Immunohistochemistry
5%
Immune Checkpoint Inhibitor
5%
Antigen
5%
